The healthcare industry is experiencing an AI-fueled surge of investment and innovation. With Large Language Models (LLMs) rapidly being utilized to tackle administrative burdens, most notably through the rise of the AI medical scribe, which promises to free doctors from endless documentation.
However, a debate is emerging over which technological path fuels this innovation. On the one hand, proprietary AI companies like OpenAI offer secure and powerful black‑box solutions via APIs. On the other hand, the open‑source community, with models like Meta’s Llama, promotes transparency and the freedom to customize.
This article will compare these models across three key areas: safety, scalability, and the potential for medical breakthroughs, to determine which one truly drives medical innovation.
Defining Open Source and Proprietary AI in Healthcare
The choice between proprietary AI and open‑source AI in healthcare is not just about cost; it is a decision about control, privacy, and interpretability. Currently, the landscape is divided into two distinct design approaches, each with major implications for its use in clinical settings.
Proprietary AI (GPT-4, Google Gemini, etc.)
Proprietary AI is closed‑source. You don't own the model; you rent access to it through an API. The company keeps the architecture, the training data, and the inner workings entirely to themselves.
- Pro: These models are polished. Companies pour millions into training them on massive datasets, including medical journals. They undergo rigorous safety testing (RLHF) to reduce harmful outputs. For a clinic that just wants a reliable AI medical scribe by tomorrow, this is the easiest path.
- Con: It's a black box. If the model misreads a patient's chart or hallucinates a symptom, you cannot ask why. There is no way to audit the decision. More importantly, your data must leave your premises to reach the vendor's servers, which can create compliance challenges for hospitals handling sensitive patient information.
Open Source AI (Llama 3, Mistral, etc.)
Open source AI is exactly what it sounds like: the model's code and trained weights are publicly available. Anyone can download them, inspect them, and modify them.
- Pro: Transparency and control. Because you host the model on your own servers, patient data never leaves the building. You can also fine-tune the model for specific medical tasks. For example, you can take a base model and train it further on thousands of oncology reports, so it learns the specific language of cancer care.
- Con: It requires great technical skill. Your team needs to know how to deploy, secure, and maintain the infrastructure. There is no customer support hotline. If the model makes a mistake, the liability falls entirely on your institution.
Head-to-Head: Safety, Scalability, and Breakthroughs
Theory is useful, but healthcare runs on results. Heres how proprietary and open‑source models actually perform when tested against the three factors that matter most: keeping patients safe, handling sensitive data at scale, and enabling real medical breakthroughs.
Safety & Compliance
The Proprietary Advantage:
Vendors like OpenAI and Google have dedicated legal and security teams. They offer ready‑made HIPAA‑compliant Business Associate Agreements (BAAs). These models also undergo extensive "red-teaming," where ethical hackers try to break the model to ensure they don't generate harmful medical advice.
The Reality of Open Source:
When you fine‑tune your own model, safety becomes your problem. If your model hallucinates a drug dosage or leaks patient data, your institution is solely liable. There is no vendor to share the blame.
The Turning Point:
However, open source offers a long‑term safety advantage that proprietary software cannot match: mechanistic interpretability. Researchers can actually trace which neurons activate when the model processes a specific diagnosis. This transparency allows teams to literally "fix" the model at the neural level when it makes mistakes.
Expert Insight: “Open-source AI is good for everyone, starting with developers who can take these models and fine-tune it, train it, distill it and use it wherever they want.” “The more open-source AI is, the more transparent and safer it becomes. It gets widely scrutinized, and that’s a good thing—because when issues are found, people, including Meta, will fix them,” - Amit Sangani, Senior Director of AI Partner Engineering at Meta
Scalability and Data Privacy: The AI Medical Scribe Use Case
An AI medical scribe listens to the doctor‑patient conversation and automatically writes the clinical note. Heres how the two paths compare.
- The Proprietary Path: Audio is captured, sent to the cloud, transcribed, and summarized. The note comes back in seconds. It is fast and requires little technical setup. But the audio, containing protected health information, has technically left the building.
- The Open Source Path: A model like Llama 3 8B runs on a local GPU server inside the clinic. The audio is converted to text on-site. The data never touches the internet.
- Scalability Result: Proprietary scales by issuing more API keys. Open source scales by buying more hardware.
- For a small practice, the API route is simpler.
- For a large hospital system handling millions of sensitive conversations, the upfront cost of GPUs is often worth the guarantee that patient data never leaves their control.
Driving Medical Innovation
Precision begins with ownership.
Where Proprietary AI Falls Short:
An API gives you access, but not control. You inherit the model's original training, its blind spots included. Prompt engineering can nudge the responses, but it cant rewire its understanding.
If your work demands fluency in the language of cardiology, oncology, or critical care, you are confined to what the base model already absorbed during pretraining. You cant retrain it.
The Open Source Advantage:
Open source changes the equation. It allows for deep customization through fine‑tuning.
Example:
Picture a research lab studying sepsis. The lab takes a base open‑source model and fine‑tunes it on 10,000 hours of ICU audio recordings, the conversations between nurses, the beeping of monitors, and the changes in a patient's voice. The result is a specialized "ICU model" that can predict septic shock hours before traditional vital sign changes.
This is not possible with a proprietary API. Privacy regulations make transmitting 10,000 hours of ICU audio to a third‑party vendor legally and ethically complicated. And even if you could, the cost of processing that much data through a paid API would be steep. Open source does not make innovation easy, but it does make it possible.
The Middle Ground: The Rise of Open Weights and Responsible Licensing
The term “open source” AI is more complicated than it sounds. Before downloading a model, healthcare organizations need to understand what they are actually working with.
- Open-Weights vs. Open Source: Many models labeled “open” are actually just open weights. This means the trained model is public, but the training data and code used to build it remain private. You can use the model, but you cant fully replicate or audit where it learned what it knows.
- Responsible AI Licenses (RAIL): Even when weights are public, the licence may restrict certain uses. Some open models include RAIL clauses that explicitly prohibit using the model for medical diagnosis without additional safety reviews. The reason for this is to prevent untested AI from being deployed in high-risk clinical settings.
- What Does This Mean for Healthcare: You cant simply download any “open” model and deploy it in a hospital. You must verify the licence terms and ensure you have the legal right to use it with patient data.
Proprietary vs. Open-Source in Practice
The table below summarizes the practical differences between the two approaches when deployed in real healthcare settings.
Feature | Proprietary AI | Open Source AI |
|---|---|---|
Data Privacy | Data leaves your premises for inference | Can be 100% on-premise |
Customization | Limited to prompt engineering | Full fine-tuning on private medical data |
Interpretability | Low (Black Box). | High (Weights are visible and editable) |
Cost Model | Operational Expense | Capital Expense |
Compliance | Vendor handles BAAs and SOC2 | Hospital handles its own validation |
Innovation Speed | Incremental (dependent on vendor releases) | Exponential (global researcher community) |
The Verdict for AI in Medicine: Which Model Drives Innovation?
After comparing safety, privacy, customization, and cost, the answer depends on what you define as “innovation.”
- Winner for Deployment Speed: Proprietary.
- If a small clinic needs an AI medical scribe functioning by next Monday and has no internal technical team, the proprietary path is the only realistic option.
- Winner for Medical Breakthroughs: Open Source.
- If a research hospital wants to push the boundaries of what AI can detect, like predicting sepsis from ICU audio or spotting rare disease patterns in radiology images, open source is the only path. It allows researchers to build specialized tools without asking permission and without sending sensitive data to third parties.
- The Future is Hybrid: Neither approach will disappear. Open-source communities will continue discovering what is technically possible, exploring new applications, and publishing breakthroughs. Proprietary platforms will take those breakthroughs, strengthen them with compliance and reliability, and deliver them at scale. The hospitals that succeed will be those that learn to use both.
Conclusion
The debate between open‑source and proprietary AI in healthcare is not about choosing a winner. It is about matching the right tool to the right job. Proprietary models deliver speed, compliance, and ease of use for organizations that need reliable solutions immediately. Open‑source models offer transparency, privacy, and the freedom to customize for those pursuing the next generation of medical breakthroughs. As the technology grows, most institutions will not limit themselves to one model. They will build hybrid strategies deploying proprietary tools for efficiency while investing in open‑source research to discover what comes next for the future of the AI medical scribe.